ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 237 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $214,777 | -17.2% | 10,306 | -4.8% | 0.15% | -10.1% |
| Q2 2023 | $259,354 | +25.2% | 10,829 | -1.6% | 0.17% | +23.4% |
| Q1 2023 | $207,170 | +18.2% | 11,008 | 0.0% | 0.14% | +11.4% |
| Q4 2022 | $175,247 | -2.6% | 11,008 | 0.0% | 0.12% | -10.9% |
| Q3 2022 | $180,000 | +16.1% | 11,008 | 0.0% | 0.14% | +21.1% |
| Q2 2022 | $155,000 | -52.7% | 11,008 | -18.6% | 0.11% | -43.8% |
| Q1 2022 | $328,000 | +20.1% | 13,516 | +15.8% | 0.20% | +18.0% |
| Q4 2021 | $273,000 | +34.5% | 11,672 | -4.1% | 0.17% | +22.0% |
| Q3 2021 | $203,000 | -31.2% | 12,172 | 0.0% | 0.14% | -9.6% |
| Q2 2021 | $295,000 | -6.1% | 12,172 | 0.0% | 0.16% | -12.8% |
| Q1 2021 | $314,000 | -51.8% | 12,172 | 0.0% | 0.18% | -57.1% |
| Q4 2020 | $651,000 | -28.1% | 12,172 | -44.5% | 0.42% | -25.4% |
| Q3 2020 | $905,000 | – | 21,921 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |